A method for the inhibition of the binding of 41 integrin to its receptors, for example VCAM-1 (vascular cell adhesion molecule-1) and fibronectin; compounds that inhibit this binding; pharmaceutically active compositions comprising such compounds; and to the use of such compounds either a above, or in formulations for the control or prevention of diseases states in which 41 is involved.

 
Web www.patentalert.com

< Intravenous fluid warming cassette with stiffening member, fluid container and key mechanism

< Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria

> Medical devices utilizing melt-processible poly(tetrafluoroethylene)

> Methods for prevention of ulcers and improving physiological performance
~ 00225